Systematic Screening of Neonatal Sickle Cell Disease with HemoTypeSC<sup>TM</sup> Kit-Test: Case Study and Literature Review

Open Journal of Blood Diseases

ISSN Print: 2164-3180
ISSN Online: 2164-3199
www.scirp.net/journal/ojbd
E-mail: [email protected]

Citations

"Systematic Screening of Neonatal Sickle Cell Disease with HemoTypeSC^TM Kit-Test: Case Study and Literature Review"
written by Emmanuel Tebandite Kasai, François Boemer, Roland Marini Djang’eing’a, Justin Kadima Ntokumunda, Salomon Batina Agasa, Nestor Ngbonda Dauly, Jean Pierre Alworong’a Opara,
published by Open Journal of Blood Diseases, Vol.10 No.1, 2020

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia
	BMC pediatrics, 2024

[2]	Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)
	International Journal of …, 2024

[3]	Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update
	…, 2023

[4]	Newborn screening for sickle cell disease in Butembo and Beni: a pilot experience in a highland region of the Democratic Republic of Congo
	Agasa, NA Uvoya… - The Pan African …, 2023

[5]	Dépistage hospitalier de la drépanocytose en République Démocratique du Congo (RDC) par HemoTypeSC: cas de la ville de Kindu
	The Pan African …, 2022

[6]	Overview of current progress and challenges in diagnosis, and management of pediatric sickle cell disease in Democratic Republic of the Congo
	…, 2022

[7]	Pairing parents and offspring's HemoTypeSC Test to validate results and confirm sickle cell pedigree: a case study in Kisangani, the Democratic Republic of the …
	…, 2022

[8]	HemoTypeSC screening for sickle cell disease in the Democratic Republic of Congo (DRC): a case from the city of Kindu
	The Pan African …, 2022

[9]	Place de l'HemoTypeSC dans le dépistage de la drépanocytose à Kindu, République Démocratique du Congo
	Revue de l'Infirmier …, 2021

[10]	Place de HemoTypeSC dans le dépistage de la drépanocytose à Kindu, République Démocratique du Congo
	2021

[11]	Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo
	2021

[12]	Faculté de médecine
	2021

[13]	Acceptability of neonatal screening of the sickle cell disease during the pandemic of COVID-19 in Kisangani, Democratic Republic of the Congo
	2020

[14]	Acceptabilité du dépistage néonatal de la drépanocytose au cours de la pandémie au COVID-19 à Kisangani, en République Démocratique du Congo
	2020

[1]	Phytochemical Characterization of Hibiscus tiliaceus L. Leaves and Evaluation of Their Antisickling, Antioxidant, and Anti-Inflammatory Activities Molecules, 2025 DOI:10.3390/molecules30081765

[2]	Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia BMC Pediatrics, 2024 DOI:10.1186/s12887-024-04805-z

[3]	Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023) International Journal of Neonatal Screening, 2024 DOI:10.3390/ijns10020038

[4]	Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update Hematology, 2023 DOI:10.1080/16078454.2023.2213043

[5]	Overview of current progress and challenges in diagnosis, and management of pediatric sickle cell disease in Democratic Republic of the Congo Hematology, 2022 DOI:10.1080/16078454.2021.2023399

[6]	Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo Hematology, 2021 DOI:10.1080/16078454.2021.1880752

	[email protected]
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Open Journal of Blood Diseases

Open Journal of Blood Diseases

Journals Menu

Guidelines & Policies

Home

About SCIRP

Service

Policies